Orkla ASA, which is represented at the board of REC, has today
subscribed for 27,755, 068 shares at a subscription price of NOK
26.50 per share in the rights issue in REC. Elkem AS which is 100 %
owned by Orkla ASA, has today subscribed for 39,977,689 shares at a
subscription price of NOK 26.50 per share in the rights issue in REC.
The subscription involves that Orkla ASA and Elkem AS subscribe for
all allotted subscription rights. At completion of the rights issue
Orkla ASA will own 108 244 768 shares and Elkem AS 155 912 989 shares
in the company, and accordingly maintain their combined ownership
interest in REC of appox. 39.73 %.
The subscription has been made on certain conditions as described in
the prospectus.
Orkla ASA
Oslo, 29 June 2009
Contact:
Rune Helland, SVP Investor Relations
Tel.: +47 2254 4411
Siv Merethe Skorpen Brekke, Orkla Investor Relations,
Tel.: +4722 544455
This announcement was originally distributed by Hugin. The issuer is
solely responsible for the content of this announcement.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.